Literature Cited

Course: WB1112
CE Original Date: November 8, 2007
CE Renewal Date: November 8, 2010
CE Expiration Date: November 8, 2012
Download Printer-Friendly Version pdf icon[PDF – 392 KB]

  1. Agency for Toxic Substances and Disease Registry (1997). “Toxicological Profile for Trichloroethylene.” U.S. Department of Health & Human Services, Public Health Service. Atlanta.
  2. American Conference of Governmental Industrial Hygienists. (2003). “TLVs & BEIs: Threshold Limit Values for Chemical Substances and Physical Agents and Biological Exposure Indices for 2003.” Cincinnati, OH.
  3. Armstrong, S. R. and L. C. Green (2004). “Chlorinated hydrocarbon solvents.” Clinics in Occupational & Environmental Medicine 4(3): 481-96.
  4. Axelson, O., K. Andersson et al. (1978). “A cohort study on trichloroethylene exposure and cancer mortality.” J Occup Med 20(3): 194-6.
  5. Axelson, O., A. Selden et al. (1994). “Updated and expanded Swedish cohort study on trichloroethylene and cancer risk.” Journal of Occupational Medicine 36(5): 556-62.
  6. Bell, D. M., D. W. Gleiber et al. (1989). “Illness associated with child day care: a study of incidence and cost.” American Journal of Public Health 79(4): 479-84.
  7. Bolt, H. M., M. Lammert et al. (2004). “Urinary alpha1-microglobulin excretion as biomarker of renal toxicity in trichloroethylene-exposed persons.” International Archives of Occupational & Environmental Health 77(3): 186-90.
  8. Bove, F., Y. Shim et al. (2002). “Drinking water contaminants and adverse pregnancy outcomes: a review.” Environmental Health Perspectives 110 Suppl 1: 61-74.
  9. Bove, F. J., M. C. Fulcomer et al. (1995). “Public drinking water contamination and birth outcomes.[see comment].” American Journal of Epidemiology 141(9): 850-62.
  10. Brauch, H., G. Weirich et al. (1999). “Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma.” Journal of the National Cancer Institute 91(10): 854-61.
  11. Brogren, C. H., J. M. Christensen et al. (1986). “Occupational exposure to chlorinated organic solvents and its effect on the renal excretion of N-acetyl-beta-D-glucosaminidase.” Archives of Toxicology Supplement 9: 460-4.
  12. Brown, L. P., D. G. Farrar et al. (1990). “Health risk assessment of environmental exposure to trichloroethylene.” Regul Toxicol Pharmacol 11(1): 24-41.
  13. Bruckner, J. V., B. D. Davis et al. (1989). “Metabolism, toxicity, and carcinogenicity of trichloroethylene.” Crit Rev Toxicol 20(1): 31-50.
  14. Bruning, T. and H. M. Bolt (2000). “Renal toxicity and carcinogenicity of trichloroethylene: key results, mechanisms, and controversies.” Critical Reviews in Toxicology 30(3): 253-85.
  15. Bruning, T., A. G. Sundberg et al. (1999). “Glutathione transferase alpha as a marker for tubular damage after trichloroethylene exposure.” Archives of Toxicology 73(4-5): 246-54.
  16. Bruning, T., S. Vamvakas et al. (1998). “Acute intoxication with trichloroethene: clinical symptoms, toxicokinetics, metabolism, and development of biochemical parameters for renal damage.” Toxicological Sciences 41(2): 157-65.
  17. Bull, R. J. (2000). “Mode of action of liver tumor induction by trichloroethylene and its metabolites, trichloroacetate and dichloroacetate.” Environmental Health Perspectives 108 Suppl 2: 241-59.
  18. Buxton, P. H. and M. Hayward (1967). “Polyneuritis cranialis associated with industrial trichloroethylene poisoning.” Journal of Neurology, Neurosurgery & Psychiatry 30(6): 511-8.
  19. Candura, S. M. and E. M. Faustman (1991). “Trichloroethylene: toxicology and health hazards.” G Ital Med Lav 13(1-6): 17-25.
  20. David, N. J., R. Wolman et al. (1989). “Acute renal failure due to trichloroethylene poisoning.” British Journal of Industrial Medicine 46(5): 347-9.
  21. Davidson, I. W. and R. P. Beliles (1991). “Consideration of the target organ toxicity of trichloroethylene in terms of metabolite toxicity and pharmacokinetics.” Drug Metab Rev 23(5-6): 493-599.
  22. Defalque, R. J. (1961). Pharmacology and toxicology of trichloroethylene. A critical review of the literature, Clinical Pharmacology & Therapeutics. 2:665-88, 1961 Sep-Oct.
  23. Fan, A. M. (1988). “Trichloroethylene: water contamination and health risk assessment.” Reviews of Environmental Contamination & Toxicology 101: 55-92.
  24. Feldman, R. G., R. F. White et al. (1985). “Long-term follow-up after single toxic exposure to trichloroethylene.” American Journal of Industrial Medicine 8(2): 119-26.
  25. Forkert, P. G., P. L. Sylvestre et al. (1985). “Lung injury induced by trichloroethylene.” Toxicology 35(2): 143-60.
  26. Goeptar, A. R., J. N. Commandeur et al. (1995). “Metabolism and kinetics of trichloroethylene in relation to toxicity and carcinogenicity. Relevance of the mercapturic acid pathway.” Chem Res Toxicol 8(1): 3-21.
  27. Goldberg, S. J., M. D. Lebowitz, et al. (1990). “An association of human congenital cardiac malformations and drinking water contaminants.” Journal of the American College of Cardiology 16(1): 155-64.
  28. Grandjean, E., R. Munchinger et al. (1955). Investigations into the effects of exposure to trichlorethylene in mechanical engineering, British Journal of Industrial Medicine. 12(2):131-42, 1955 Apr.
  29. Green, T. (2000). “Pulmonary toxicity and carcinogenicity of trichloroethylene: species differences and modes of action.” Environ Health Perspect 108 Suppl 2: 261-4.
  30. Green, T., J. Dow et al. (2004). “Biological monitoring of kidney function among workers occupationally exposed to trichloroethylene.” Occupational & Environmental Medicine 61(4): 312-7.
  31. HSDB (April 2006). “Hazardous Substances Data Bank.” National Library of Medicine, National Toxicology Information Program, Bethesda, MD.
  32. Iavicoli, I., A. Marinaccio et al. (2005). “Effects of occupational trichloroethylene exposure on cytokine levels in workers.” Journal of Occupational & Environmental Medicine 47(5): 453-7.
  33. Joron, G. E., D. G. Cameron et al. (1955). Massive necrosis of the liver due to trichlorethylene, Canadian Medical Association Journal. 73(11):890-1, 1955 Dec 1.
  34. Kaneko, T., P. Y. Wang et al. (1997). “Assessment of the health effects of trichloroethylene.” Ind Health 35(3): 301-24.
  35. Kimbrough, R. D., F. L. Mitchell et al. (1985). “Trichloroethylene: an update.” J Toxicol Environ Health 15(3-4): 369-83.
  36. King, G. S., J. E. Smialek et al. (1985). “Sudden death in adolescents resulting from the inhalation of typewriter correction fluid.” JAMA 253(11): 1604-6.
  37. Kleinfeld, M. and I. R. Tabershaw (1954). Trichloroethylene toxicity; report of five fatal cases, A. M. A. Archives of Industrial Hygiene & Occupational Medicine. 10(2):134-41, 1954 Aug.
  38. Lash, L. H., J. W. Fisher et al. (2000). “Metabolism of trichloroethylene.” Environ Health Perspect 108 Suppl 2: 177-200.
  39. Lash, L. H., J. C. Parker et al. (2000). “Modes of action of trichloroethylene for kidney tumorigenesis.” Environmental Health Perspectives 108 Suppl 2: 225-40.
  40. Lawrence, W. H. and E. K. Partyka (1981). “Chronic dysphagia and trigeminal anesthesia after trichloroethylene exposure.” Annals of Internal Medicine 95(6): 710.
  41. Lipscomb, J. C., C. M. Garrett et al. (1997). “Cytochrome P450-dependent metabolism of trichloroethylene: interindividual differences in humans.” Toxicol Appl Pharmacol 142(2): 311-8.
  42. Maltoni, C., G. Lefemine et al. (1988). “Long-term carcinogenicity bioassays on trichloroethylene administered by inhalation to Sprague-Dawley rats and Swiss and B6C3F1 mice.” Annals of the New York Academy of Sciences 534: 316-42.
  43. Massachusetts Department of Public Health, C. f. D. C. a. P., Massachusetts Health Research Institute, (1996). “Final Report of the Woburn Environmental and Birth Study.” Cambridge, MA: Massachusetts Department of Public Health.
  44. Meditext (2004). “Trichloroethylene.” Denver, Micromedex, Inc.
  45. Miller, P. W., M. B. Mycyk et al. (2002). “An unusual presentation of inhalant abuse with dissociative amnesia.” Veterinary & Human Toxicology 44(1): 17-9.
  46. Monster, A. C., G. Boersma et al. (1976). “Pharmacokinetics of trichloroethylene in volunteers, influence of workload and exposure concentration.” International Archives of Occupational & Environmental Health 38(2): 87-102.
  47. Monster, A. C., G. Boersma et al. (1979). “Kinetics of trichloroethylene in repeated exposure of volunteers.” International Archives of Occupational & Environmental Health 42(3-4): 283-92.
  48. Moore, M. M. and K. Harrington-Brock (2000). “Mutagenicity of trichloroethylene and its metabolites: implications for the risk assessment of trichloroethylene.” Environmental Health Perspectives 108 Suppl 2: 215-23.
  49. Nagaya, T., N. Ishikawa et al. (1989). “Urinary total protein and beta-2-microglobulin in workers exposed to trichloroethylene.” Environmental Research 50(1): 86-92.
  50. NIDA (2005). “Research Report Series: Inhalant abuse.” NIH Publication Number 05-3818.
  51. Nomiyama, K. and H. Nomiyama (1977). “Dose-response relationship for trichloroethylene in man.” International Archives of Occupational & Environmental Health 39(4): 237-48.
  52. Norris, W. and P. Stuart (1957). Cardiac arrest during trichlorethylene anaesthesia, British Medical Journal. (5023):860-3, 1957 Apr 13.
  53. NTP (2004). “Trichloroethylene CAS No. 79-01-6.” Eleventh Report on Carcinogens. Research Triangle Park, NC. National Toxicology Program.
  54. OSHA (1993). “Air contaminants final rule.” Occupational Safety and Health Administration. Federal Register 58:35338-35351.
  55. Rasmussen, K., C. H. Brogren et al. (1993). “Subclinical affection of liver and kidney function and solvent exposure.” International Archives of Occupational & Environmental Health 64(6): 445-8.
  56. Reif, J. S., J. B. Burch et al. (2003). “Neurobehavioral effects of exposure to trichloroethylene through a municipal water supply.” Environ Res 93(3): 248-58.
  57. Rosenman, K. D., M. J. Reilly et al. (2003). “Cleaning products and work-related asthma.” Journal of Occupational & Environmental Medicine 45(5): 556-63.
  58. Salvini, M., S. Binaschi et al. (1971). “Evaluation of the psychophysiological functions in humans exposed to trichloroethylene.” British Journal of Industrial Medicine 28(3): 293-5.
  59. Sanders, V. M., A. N. Tucker et al. (1982). “Humoral and cell-mediated immune status in mice exposed to trichloroethylene in the drinking water.” Toxicology & Applied Pharmacology 62(3): 358-68.
  60. Sato, A., T. Nakajima et al. (1977). “A pharmacokinetic model to study the excretion of trichloroethylene and its metabolites after an inhalation exposure.” British Journal of Industrial Medicine 34(1): 56-63.
  61. Selden, A., B. Hultberg et al. (1993). “Trichloroethylene exposure in vapour degreasing and the urinary excretion of N-acetyl-beta-D-glucosaminidase.” Arch Toxicol 67(3): 224-6.
  62. Shindell, S. and S. Ulrich (1985). “A cohort study of employees of a manufacturing plant using trichlorethylene.” Journal of Occupational Medicine 27(8): 577-9.
  63. Spirtas, R., P. A. Stewart et al. (1991). “Retrospective cohort mortality study of workers at an aircraft maintenance facility. I. Epidemiological results.” British Journal of Industrial Medicine 48(8): 515-30.
  64. Stewart, R. D., C. L. Hake et al. (1974). “”Degreaser’s flush.” Arch Environ Health 29(1): 1-5.
  65. Stewart RD, H. C., Le Brun AI et al, (1974a). “Effects of trichloroethylene on behavioral performance capabilities.” In: Xintaras C, Johnson BL, Groot I, eds. HEW Publication no. (NIOSH)74-126. US Department of Health, Education and Welfare, Washington DC, 96-129.
  66. Szlatenyi, C. S. and R. Y. Wang (1996). “Encephalopathy and cranial nerve palsies caused by intentional trichloroethylene inhalation.” Am J Emerg Med 14(5): 464-6.
  67. Thiele, D. L., E. H. Eigenbrodt et al. (1982). “Cirrhosis after repeated trichloroethylene and 1,1,1-trichloroethane exposure.” Gastroenterology 83(4): 926-9.
  68. Tola, S., R. Vilhunen et al. (1980). “A cohort study on workers exposed to trichloroethylene.” Journal of Occupational Medicine 22(11): 737-40.
  69. U.S. EPA (2003). “Toxic Release Inventory.” Washington, DC: U.S. Environmental Protection Agency.
  70. US Environmental Protection Agency (1985). “Health assessment document for trichloroethylene. Final report.” Washington: US Environmental Protection Agency. NTIS Report No. PB/85-249696.
  71. Waksman, J. C. and S. D. Phillips (2004). “Biologic markers of exposure to chlorinated solvents.” Clinics in Occupational & Environmental Medicine 4(3): 413-21.
  72. Wartenberg, D., D. Reyner et al. (2000). “Trichloroethylene and cancer: epidemiologic evidence.[see comment].” Environmental Health Perspectives 108 Suppl 2: 161-76.
  73. Waters, E. M., H. B. Gerstner et al. (1977). “Trichloroethylene. I. An overview.” Journal of Toxicology & Environmental Health 2(3): 671-707.
  74. WHO (1985). “Trichloroethylene.” Environmental Health Criteria 50. World Health Organization, Geneva.
  75. Windham, G. C., D. Shusterman et al. (1991). “Exposure to organic solvents and adverse pregnancy outcome.” American Journal of Industrial Medicine 20(2): 241-59.
  76. Wu, C. and J. Schaum (2000). “Exposure assessment of trichloroethylene.” Environmental Health Perspectives 108 Suppl 2: 359-63.
Page last reviewed: December 10, 2013